Posts in tag

Ozempic


Eli Lilly’s Mounjaro would need “substantial price reduction”, says PBAC Mounjaro, the type-2 diabetes medication that the New York Times recently predicted “’could overshadow Ozempic” has been refused funding via …

Novo Nordisk’s diabetes medication, Ozempic (semaglutide) and weight-loss treatment Saxenda (liraglutide) are being investigated, following reports they may be associated with suicidal ideation  The European Medicines Agency (EMA) is looking …

TGA underscores ‘limited availability’ means drug should still only be prescribed for type-2 diabetes There will be continued “limited availability” of diabetes drug Ozempic until 31 December 2023 due to …

Concerns Ozempic ingredient may be related to thyroid cancer and suicide ideation draws attention of EMA Semaglutide, the active ingredient in hyped diabetes and weight loss drug, Ozempic and others, …

New guidelines this week will ban “tick-and-flick” online “consultations” The Medical Board will hand down new guidelines on Thursday (June 1 2023) that will stop telehealth doctors from prescribing to …

Ozempic/Wegovy sponsor trumpets results of Phase III clinical trial as its halts US ads A trial of an oral version of Novo Nordisk’s obesity and diabetes medication semaglutide, the active …

Test of two separate imports showed they contained no semaglutide As the Ozempic shortage continues at least until the end of June, the Therapeutic Goods Administration (TGA) has detected counterfeit …

Two opposing forces lobbied for different ways to save patients money this week, while there was lots of medicines news and we looked at burnout in hospitals There was bad …

Just when you thought supplies were improving, sponsor and TGA now foresee supply problems until end of June 2023 It was a brief respite but now much-hyped diabetes and more-often-than-not …

Australians looking to access supplies of diabetes medication Ozempic (semaglutide) are being urged not to source the drug online  Patients turning to Google to find supplies of Ozempic are putting …

Double dispensing, pharmacist prescribing and women in pharmacy were all key issues which made the news this week We heard that some health practitioners have had their details stolen in …

One pharmacy stakeholder is worried that some prescribers’ identities have been stolen to make an Ozempic scam look more convincing And pharmacists concerned the same could have happened to them …